Mammomat Revelation
2017-11-27
Mammomat Revelation
Nov 26, 2017
Mammomat Revelation enables providers to expand precision medicine, improve clinical operations and increase patient satisfaction.
Did this information help you?
The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Further details are available from the local Siemens Healthineers organizations.
Mammomat Revelation's current FDA approval status is currently "510k pending".
Reference Number: IM2017110118HCEN